201 related articles for article (PubMed ID: 33326670)
1. Human herpesvirus 6 reactivation in unmanipulated haploidentical hematopoietic stem cell transplantation predicts the occurrence of grade II to IV acute graft-versus-host disease.
Han TT; Zhang YN; Sun YQ; Kong J; Wang FR; Wang ZD; Cheng YF; Yan CH; Wang Y; Xu LP; Zhang XH; Liu KY; Huang XJ; Zhao XS
Transpl Infect Dis; 2021 Jun; 23(3):e13544. PubMed ID: 33326670
[TBL] [Abstract][Full Text] [Related]
2. Impact of Human Herpesvirus-6 Reactivation on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation.
Aoki J; Numata A; Yamamoto E; Fujii E; Tanaka M; Kanamori H
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2017-22. PubMed ID: 26226409
[TBL] [Abstract][Full Text] [Related]
3. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
4. Long-term prognosis of human herpesvirus 6 reactivation following allogeneic hematopoietic stem cell transplantation.
Iesato K; Hori T; Yoto Y; Yamamoto M; Inazawa N; Kamo K; Ikeda H; Iyama S; Hatakeyama N; Iguchi A; Sugita J; Kobayashi R; Suzuki N; Tsutsumi H
Pediatr Int; 2018 Jun; 60(6):547-552. PubMed ID: 29542206
[TBL] [Abstract][Full Text] [Related]
5. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
Wang LR; Dong LJ; Zhang MJ; Lu DP
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
[TBL] [Abstract][Full Text] [Related]
6. Reactivation of Human Herpes Virus-6 After Pediatric Stem Cell Transplantation: Risk Factors, Onset, Clinical Symptoms and Association With Severity of Acute Graft-Versus-Host Disease.
Verhoeven DH; Claas EC; Jol-van der Zijde CM; Thijssen JC; Lankester AC; Bredius RG; Putter H; Kroes AC; Egeler RM; Schilham MW; van Tol MJ
Pediatr Infect Dis J; 2015 Oct; 34(10):1118-27. PubMed ID: 26132825
[TBL] [Abstract][Full Text] [Related]
7. Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation.
Vittayawacharin P; E'Leimat G; Lee BJ; Griffin S; Doh J; Nam H; Blodget E; Jeyakumar D; Kongtim P; Ciurea SO
Transplant Cell Ther; 2023 Jun; 29(6):397.e1-397.e6. PubMed ID: 36878429
[TBL] [Abstract][Full Text] [Related]
8. Low incidence of HHV-6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft-vs-host disease prophylaxis compared with cord blood transplantation.
Tamaki H; Ikegame K; Yoshihara S; Kaida K; Yoshihara K; Inoue T; Kato R; Nakata J; Fujioka T; Soma T; Okada M; Ogawa H
Transpl Infect Dis; 2019 Jun; 21(3):e13073. PubMed ID: 30875143
[TBL] [Abstract][Full Text] [Related]
9. The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus-6B encephalitis after naïve T-cell-depleted allogeneic stem cell transplantation.
Gasior M; Ferreras C; de Paz R; Bueno D; Mozo Y; Sisinni L; Canizales JT; González B; Olivas-Mazón R; Marcos A; Romero AB; Constanzo A; Mirones I; Fernández-Arroyo A; Balas A; Vicario JL; Escudero A; Yuste VJ; Pérez-Martínez A
Transfusion; 2021 May; 61(5):1505-1517. PubMed ID: 33713461
[TBL] [Abstract][Full Text] [Related]
10. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
[TBL] [Abstract][Full Text] [Related]
11. Reactivation of human herpesvirus 6 in pediatric allogeneic hematopoietic stem cell transplant recipients.
Pawlowska AB; Karras NA; Liu H; DiMundo J; Cheng JC; Sun W; Armenian S; Yang D; Palmer JM; Bell A; Tahoun A; Tegtmeier B; Dadwal S; Rosenthal J
Transpl Infect Dis; 2021 Feb; 23(1):e13453. PubMed ID: 32860467
[TBL] [Abstract][Full Text] [Related]
12. Optimal Active Anti-Thymocyte Globulin Exposure Associated with Minimum Risk of Virus Reactivation and Comparable Acute Graft-Versus-Host Disease Under Adult Myeloablative Haploidentical Peripheral Blood Stem Cell Transplantation.
Wang H; Zhao Y; Fang S; Wang L; Peng B; Yang J; Wang N; Du J; Li F; Jin X; Luan S; Wu X; Dou L; Liu D
Transplant Cell Ther; 2022 Jun; 28(6):332.e1-332.e10. PubMed ID: 35314377
[TBL] [Abstract][Full Text] [Related]
13. The complex relationship between human herpesvirus 6 and acute graft-versus-host disease.
Pichereau C; Desseaux K; Janin A; Scieux C; Peffault de Latour R; Xhaard A; Robin M; Ribaud P; Agbalika F; Chevret S; Socié G
Biol Blood Marrow Transplant; 2012 Jan; 18(1):141-4. PubMed ID: 21801705
[TBL] [Abstract][Full Text] [Related]
14. Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome.
Greco R; Crucitti L; Noviello M; Racca S; Mannina D; Forcina A; Lorentino F; Valtolina V; Rolla S; Dvir R; Morelli M; Giglio F; Barbanti MC; Lupo Stanghellini MT; Oltolini C; Vago L; Scarpellini P; Assanelli A; Carrabba MG; Marktel S; Bernardi M; Corti C; Clementi M; Peccatori J; Bonini C; Ciceri F
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2250-2255. PubMed ID: 27697585
[TBL] [Abstract][Full Text] [Related]
15. Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Inui Y; Yakushijin K; Okamura A; Tanaka Y; Shinzato I; Nomura T; Ichikawa H; Mizutani Y; Kitao A; Kurata K; Kakiuchi S; Miyata Y; Sanada Y; Kitagawa K; Uryu K; Kawamoto S; Yamamoto K; Matsuoka H; Murayama T; Ito M; Minami H
Transpl Infect Dis; 2019 Feb; 21(1):e13024. PubMed ID: 30414316
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
17. Human herpesvirus-6B infection in pediatric allogenic hematopoietic stem cell transplant patients: Risk factors and encephalitis.
Miura H; Kawamura Y; Hattori F; Tanaka M; Kudo K; Ihira M; Yatsuya H; Takahashi Y; Kojima S; Sakaguchi H; Yoshida N; Hama A; Yoshikawa T
Transpl Infect Dis; 2020 Feb; 22(1):e13203. PubMed ID: 31650671
[TBL] [Abstract][Full Text] [Related]
18. Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation.
Wang LR; Dong LJ; Zhang MJ; Lu DP
Bone Marrow Transplant; 2008 Nov; 42(10):673-7. PubMed ID: 18695666
[TBL] [Abstract][Full Text] [Related]
19. Human Herpesvirus 6 Reactivation Evaluated by Digital Polymerase Chain Reaction and Its Association With Dynamics of CD134-Positive T Cells After Allogeneic Hematopoietic Stem Cell Transplantation.
Nakayama H; Yamazaki R; Kato J; Koda Y; Sakurai M; Abe R; Watanuki S; Sumiya C; Shiroshita K; Fujita S; Yamaguchi K; Okamoto S; Mori T
J Infect Dis; 2019 Aug; 220(6):1001-1007. PubMed ID: 31063196
[TBL] [Abstract][Full Text] [Related]
20. HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation.
Zerr DM; Boeckh M; Delaney C; Martin PJ; Xie H; Adler AL; Huang ML; Corey L; Leisenring WM
Biol Blood Marrow Transplant; 2012 Nov; 18(11):1700-8. PubMed ID: 22641196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
